Abstracts
Conclusion -Les effets d'une exposition prolongée au CO à des concentrations telles que rencontrées en environnement urbain, sont masqués dans des conditions standards, mais apparaissent majeurs et délétères consécutivement à un stress oxydant aigu au H2O2. La NOS2 semble être impliquée de manière majeure dans les effets délétères du CO.
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We demonstrated an increase of nitric oxide (NO) production in aortas of zucker obese fatty rat (ZOF). Metabolic syndrome is associated with an attenuation of acetylcholine (ACh) response. The impairment of ACh induced vasodilation suggests a decrease in nitric oxide (NO) bioavailability. The aim of this work was to assess whether a reduced NO production is involved in the drop of NO bioavailability. Male zucker obese fatty (ZOF, n=8) and lean (n=9) rats, 31 weeks old, were anesthetized and thoracic aortic segments harvested. The NO produced by aortic rings was assayed by EPR spectroscopy using colloid Fe(DETC)2 spin-trapping. The EPR spectra were obtained using a X-Band EPR spectrometer. Basal NO production was signiÀ cantly (p=0.0001) increase (126 %) in ZOF rats (3061±201AU/h/mg) from lean controls (1356±101AU/h/ mg). Addition of ACh (3.10-6M) induced an increase in NO levels in aortic rings of both ZOF and lean rats, this relative increase was signiÀ cantly smaller in ZOF (162±10 vs 270±26 %, p=0.002). However the level was higher in ZOF (4905±360 vs 3500±213AU/h/ mg, p=0.004). Without endothelium no NO production was detecded in ZOF aortas. A speciÀ c inhibitor of neuronal NOS, NwPropyl-L-arginine (PLA ; 0,1 õm), was unable to decreased both NO productions : the basal NO production and the ACh-stimulated NO production in ZOF aortas. A similar result was obtained with the speciÀ c inhibitor of inducible NOS suggesting the only involvement of eNOS in increase of NO production observed in ZOF. We conclude that the vascular dysfunction observed in metabolic syndrome is not due to a decrease in NO production but may be at least in part due to a reduced sensitivity to ACh stimulation. Resistance arteries have a key role in the control of local blood Á ow. They are able to remodel in response to chronic increases in Á ow during growth, exercising or in ischemic diseases. Flow-mediated remodelling is governed by the endothelium. The incidence of metabolic syndrome increases with age and these 2 risk factors reduce endothelium integrity, because of an inÁ ammatory process. We hypothesized that inÁ ammation possibly through the induction of cycloxygenase-2 (COX2), might affect remodeling in old obese rats. In 12-month old obese and lean Zucker rats mesenteric resistance arteries were alternatively ligated in vivo so that one artery was submitted to high Á ow (HF), compare to normal Á ow (NF) vessels.
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CYCLOXYGENASE-2 PRESERVES FLOW-MEDIATED REMODELING IN OLD OBESE ZUCKER RATS RESISTANCE ARTERIES
After 21 days, outward hypertrophic remodelling in HF arteries occurred in obese rats (498±20 in HF arteries vs 443±18 õm in NF arteries, P<0.01), not in lean rats (454±17 vs 432±14, NS ; n=12 per group). Endothelium-dependent (acetylcholine)-relaxation (AMR) was reduced in obese compare to lean rats. AMR was reduced by NO-synthesis blockade (L-NAME) in all groups and eNOS expression was higher in HF than in NF arteries without difference between lean and obese rats. Indomethacin further reduced AMR in HF from obese rats without signiÀ cantly affecting arteries from lean animals. As COX2 immunostaining and expression level was evidenced in arteries from obese rats, COX2 inhibition (NS398) was tested on AMR. NS398 signiÀ cantly reduced AMR in HF arteries in obese rats only. In obese rats chronically treated (3 weeks) with NS398 outward remodelling did not occurred in HF arteries.
Thus, COX2 preserved arterial remodelling in response to a chronic rise in blood Á ow in old obese rats. This adaptation is in favor of a better tissue perfusion.
C004
CYCLOOXYGENASE-2 INHIBITION RESTORED ENDOTHELIAL-MEDIATED RELAXATION IN OLD OBESE
End-organs perfusion is altered in metabolic diseases due in part to a decreased endothelium-mediated relaxation in resistance arteries (RA). InÁ ammatory factors including cyclooxygenase-2 (COX2) derived agents affect the endothelium to different degrees in aging and obesity but the effect of their association on the endothelium is not fully understood. We hypothesized that COX2 derivatives might reduce endothelium-mediated relaxation in aging associated with obesity. RA from 4 and 12 month-old obese Zucker rats RA were isolated to measure acetylcholine (endothelium)-mediated relaxation (AMR), in vitro, using wire-myography.
Impaired with obesity in young rats, AMR was further reduced with aging in old obese rats (89 versus 77 % maximal relaxation, young versus old lean rats and 72 versus 51 %, old young versus old obese rats). Endothelial NO-synthase (eNOS) blockade (L-NAME) was reduced in old obese rats although eNOS expression level was unaffected. However, indomethacin improved AMR in old obese rats only, suggesting that vasoconstrictor prostanoids were involved. Similarly, COX2 inhibition (NS398) and TxA2/PGH2 receptor blockade (SQ29548) increased AMR in arteries from old obese rats only. Old obese rats presented the highest levels of blood TxB2 (TxA2 metabolite) associated with an increased COX2 immunostaining and expression level. Chronic inhibition of COX2 with NS398 (3 weeks) restored AMR in old obese rats (78 % versus 57 % in control obese rats) to the level observed in solventtreated old lean rats (84 %). Taken together, these data show that obesity in old rats is associated with a reduced endothelium-mediated relaxation due to an excessive production of COX-2 derivatives, most probably TxA2. Objective -To study the role of the serotoninergic 5-HT2B receptor in the development of cardiac hypertrophy and its link with left ventricular superoxide anion generation in a mouse model of angiotensin II-induced hypertension.
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SEROTONINERGIC 5-HT2B RECEPTOR BLOCKADE PREVENTS SUPEROXIDE ANION MEDIATED CARDIAC HYPERTROPHY INDUCED BY ANGIOTENSIN II
Methods -Wild-type and 5-HT2B receptor knock-out (KO) mice were perfused with angiotensin II (0.2 mg.kg-1.d-1) for 14 days with or without SB215505 (1mg.kg-1.d-1), an antagonist of the 5-HT2B receptor. Heart rate and blood pressure were measured by tail-cuff plethysmography. Cardiac hypertrophy was evaluated by echocardiography and direct measurement of heart weight. Superoxide anion production and maximal NAD(P)H oxidase activity were measured by a chemiluminescence method using lucigenin. Superoxide anion production was also measured in primary left ventricular À broblasts cell cultures.
Results -Angiotensin II increased superoxide anion production (+32 %), the maximal activity of NAD(P)H oxidase (+84 %) in left ventricle of wild-type mice concomitantly with the arterial blood pressure (+37mmHg) and the heart/body weight ratio (+17 %). A pharmacological blockade (SB215505) or a genetic suppression of the 5-HT2B receptor prevented the increased superoxide anion production and cardiac hypertrophy but had no effect on cardiac hemodynamics or blood pressure. Angiotensin II also increased NAD(P)H oxidase activity in cultured cardiac À broblasts and this increase was prevented by SB215505.
Conclusion -The 5-HT2B receptor is a new potential target for the prevention of cardiac hypertrophy and its associated superoxide anion production. Cells of the extracellular matrix could possibly be involved in this mechanism. Nitric oxide (NO) production by endothelial NO-synthase (eNOS) is critically dependent on the cofactor, tetrahydrobiopterin (BH4). Depletion in BH4 consecutive to an increase of reactive oxygen species (ROS) production by NADPH-oxidases and/or eNOS overexpression, favour eNOS uncoupling. This study investigates the potential role of NADPH-oxidases and uncoupled eNOS in pulmonary arterial hypertension induced by chronic hypoxia.
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NADPH-OXIDASES AND UNCOUPLED ENDOTHELIAL NO-SYNTHASE IN PULMONARY ARTERIAL HYPERTENSION INDUCED BY CHRONIC HYPOXIA
Male C57BL/6 and eNOS knockout (eNOS-/-) mice were exposed or not to hypobaric hypoxia (0.5 atm) for 21 days. Fulton index (right ventricular / left ventricular + septum weight ratio) was determined. Lungs were used for measurement of BH4 (by HPLC), for expression of eNOS (by western-blotting) and of the NADPHoxidases subunits Nox1, Nox2 and Nox4 (by RT-PCR). Pulmonary arteries were also mounted in a wire myograph for evaluation of vasomotor responses.
Chronic hypoxia induced a marked up-regulation of Nox1, Nox2 and Nox4 mRNAs in lungs, and an increase of ROS levels in pulmonary arteries. BH4 levels, as well as eNOS expression, were enhanced in lungs from hypoxic WT mice (1.25 and 4 fold increase compared to normoxic WT mice, respectively). In pulmonary arteries from hypoxic WT mice, the contractile response to phenylephrine was about 1.8 greater than in those from normoxic WT mice. The use of ROS scavengers (PEG-SOD or catalase) and NOS inhibitor (L-NAME) revealed the involvement of ROS in hypoxia-induced hyper-reactivity to phenylephrine, and a loss of NO-dependent relaxation. Chronic treatment of hypoxic WT mice with the BH4 precursor sepiapterin preserved the vasorelaxant effect of NO. This treatment and the deletion of eNOS gene abolished the inhibitory effect of catalase on phenylephrine-induced contraction, and also attenuated hypoxia-induced right ventricular hypertrophy.
These data show that chronic hypoxia induced an up-regulation of Nox isoforms and eNOS in lungs. They suggest that uncoupled eNOS participates to right ventricular hypertrophy and to alterations of vasomotor responses in pulmonary arteries in hypoxia-induced pulmonary hypertension. The weak increase in BH4 and the large over-expression of eNOS suggest the existence of compensatory mechanisms on BH4 synthesis, which may moderate eNOS dysfunction.
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